← Latest Filings
R

Redmile Group, LLC

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
5
$40.9M total
Open-market sells
7
$20.2M total
Tracking since
Dec 2024
Activity timeline
Open-market buy — $6.8M
Attovia Therapeutics, Inc. · Aug 6, 2026
Open-market buy — $3.4M
Attovia Therapeutics, Inc. · Aug 6, 2026
Open-market trades from the last two years.

10 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
12,884,277 Common Stock in FATE
Held indirectly (See Footnote) · as of 2024-12-20
12,827,946 Common Stock in FATE
Held indirectly (See Footnotes) · as of 2024-12-12

15 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
FATE THERAPEUTICS INC
CIK 0001434316
Atara Biotherapeutics, Inc.
CIK 0001604464

2 more companies. A free account shows you more; Premium shows every one.

Log in